Company intelligence / Profile preview
OrthoSera
Krems an der Donau, Lower Austria, Austriaorthosera.com ↗
- Ownership
- Private
- Employees
- ~24
- Development stage
- Commercial
01
Overview
OrthoSera has commercialized its albumin-coated bone allograft product BoneAlbumin™ in Europe with demonstrated clinical benefit in orthopedic and dental applications. Its next-generation hyperacute serum therapy hypACT™ has shown promising results compared to PRP and other blood derivatives in osteoarthritic tissue models and is being clinically administered with ongoing data collection. The company also develops point-of-care devices for autologous serum production.
Clinical studies have shown improved outcomes with their products over several years of follow-up.- Therapeutic areas
- OtherDermatologyInfectious DiseasesRheumatology
- Modalities
- Blood derivatives (serum-based therapies)Albumin-coated bone allograftsAutologous serum productsHyperacute serum (hypACT™)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Investors include FastVentures, Euroventures, Futurmed; no major pharma partnerships listed.
Beyond the preview
Go deeper on OrthoSera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OrthoSera.